Works matching IS 15588211 AND DT 2014 AND VI 9 AND IP 2
Results: 14
Novel Antibody Therapy in Acute Lymphoblastic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 165, doi. 10.1007/s11899-014-0202-9
- By:
- Publication type:
- Article
The Use of Molecular Genetics to Refine Prognosis in Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 148, doi. 10.1007/s11899-014-0208-3
- By:
- Publication type:
- Article
Recent Discoveries in Molecular Characterization of Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 93, doi. 10.1007/s11899-014-0200-y
- By:
- Publication type:
- Article
Novel Therapeutics in Acute Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 109, doi. 10.1007/s11899-014-0199-0
- By:
- Publication type:
- Article
Is Targeted Therapy Feasible in Acute Myelogenous Leukemia?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 118, doi. 10.1007/s11899-014-0198-1
- By:
- Publication type:
- Article
Treatment of Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 186, doi. 10.1007/s11899-014-0209-2
- By:
- Publication type:
- Article
What is the Standard Regimen for Patients with Acute Promyelocytic Leukemia?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 138, doi. 10.1007/s11899-014-0206-5
- By:
- Publication type:
- Article
Frontline Therapy of AML: Should the Older Patient be Treated Differently?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 100, doi. 10.1007/s11899-014-0211-8
- By:
- Publication type:
- Article
Pediatric-Like Therapy for Adults with ALL.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 158, doi. 10.1007/s11899-014-0210-9
- By:
- Publication type:
- Article
Contemporary Treatment of APL.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 193, doi. 10.1007/s11899-014-0205-6
- By:
- Publication type:
- Article
In Memory of Professor John Michael Goldman.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 91, doi. 10.1007/s11899-014-0201-x
- By:
- Publication type:
- Article
FLT3 Inhibitors in AML: Are We There Yet?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 174, doi. 10.1007/s11899-014-0203-8
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: Are We Closer to Knowing Who Needs It?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 128, doi. 10.1007/s11899-014-0207-4
- By:
- Publication type:
- Article
Incorporating Tyrosine Kinase Inhibitors into Treatment Regimens for AML and ALL: Is There a Right or Wrong Way?
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 2, p. 144, doi. 10.1007/s11899-014-0204-7
- By:
- Publication type:
- Article